Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Associations of Hearing Loss and Menopausal Hormone Therapy With Change in Global Cognition and Incident Cognitive Impairment Among Postmenopausal Women.
Armstrong NM, Espeland MA, Chen JC, Masaki K, Wactawski-Wende J, Li W, Gass MLS, Stefanick ML, Manson JE, Deal JA, Rapp SR, Lin FR, Resnick SM. Armstrong NM, et al. Among authors: gass mls. J Gerontol A Biol Sci Med Sci. 2020 Feb 14;75(3):537-544. doi: 10.1093/gerona/glz173. J Gerontol A Biol Sci Med Sci. 2020. PMID: 31326978 Free PMC article.
Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D; WHIMS Investigators. Rapp SR, et al. JAMA. 2003 May 28;289(20):2663-72. doi: 10.1001/jama.289.20.2663. JAMA. 2003. PMID: 12771113 Clinical Trial.
Corrigendum to: Associations of Hearing Loss and Menopausal Hormone Therapy With Change in Global Cognition and Incident Cognitive Impairment Among Postmenopausal Women.
Armstrong NM, Espeland MA, Chen JC, Masaki K, Wactawski-Wende J, Li W, Gass MLS, Stefanick ML, Manson JE, Deal JA, Rapp SR, Lin FR, Resnick SM. Armstrong NM, et al. Among authors: gass mls. J Gerontol A Biol Sci Med Sci. 2020 Apr 17;75(5):1017. doi: 10.1093/gerona/glz208. J Gerontol A Biol Sci Med Sci. 2020. PMID: 31624848 Free PMC article. No abstract available.
Breast cancer after use of estrogen plus progestin in postmenopausal women.
Chlebowski RT, Kuller LH, Prentice RL, Stefanick ML, Manson JE, Gass M, Aragaki AK, Ockene JK, Lane DS, Sarto GE, Rajkovic A, Schenken R, Hendrix SL, Ravdin PM, Rohan TE, Yasmeen S, Anderson G; WHI Investigators. Chlebowski RT, et al. N Engl J Med. 2009 Feb 5;360(6):573-87. doi: 10.1056/NEJMoa0807684. N Engl J Med. 2009. PMID: 19196674 Free PMC article. Clinical Trial.
Relation of Pregnancy Loss to Risk of Cardiovascular Disease in Parous Postmenopausal Women (From the Women's Health Initiative).
Hall PS, Nah G, Vittinghoff E, Parker DR, Manson JE, Howard BV, Sarto GE, Gass ML, Sealy-Jefferson SM, Salmoirago-Blotcher E, Stefanick ML, Shadyab AH, Van Horn LV, Park K, Parikh NI. Hall PS, et al. Am J Cardiol. 2019 May 15;123(10):1620-1625. doi: 10.1016/j.amjcard.2019.02.012. Epub 2019 Feb 22. Am J Cardiol. 2019. PMID: 30871746 Free PMC article.
Circulating estrogens and postmenopausal ovarian and endometrial cancer risk among current hormone users in the Women's Health Initiative Observational Study.
Trabert B, Coburn SB, Falk RT, Manson JE, Brinton LA, Gass ML, Kuller LH, Rohan TE, Pfeiffer RM, Qi L, Stefanick ML, Wentzensen N, Anderson GL, Xu X. Trabert B, et al. Cancer Causes Control. 2019 Nov;30(11):1201-1211. doi: 10.1007/s10552-019-01233-8. Epub 2019 Sep 21. Cancer Causes Control. 2019. PMID: 31542834 Free PMC article.
Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women.
Chlebowski RT, Anderson GL, Gass M, Lane DS, Aragaki AK, Kuller LH, Manson JE, Stefanick ML, Ockene J, Sarto GE, Johnson KC, Wactawski-Wende J, Ravdin PM, Schenken R, Hendrix SL, Rajkovic A, Rohan TE, Yasmeen S, Prentice RL; WHI Investigators. Chlebowski RT, et al. JAMA. 2010 Oct 20;304(15):1684-92. doi: 10.1001/jama.2010.1500. JAMA. 2010. PMID: 20959578 Free PMC article. Clinical Trial.
Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.
Chlebowski RT, Anderson GL, Aragaki AK, Manson JE, Stefanick ML, Pan K, Barrington W, Kuller LH, Simon MS, Lane D, Johnson KC, Rohan TE, Gass MLS, Cauley JA, Paskett ED, Sattari M, Prentice RL. Chlebowski RT, et al. Among authors: gass mls. JAMA. 2020 Jul 28;324(4):369-380. doi: 10.1001/jama.2020.9482. JAMA. 2020. PMID: 32721007 Free PMC article. Clinical Trial.
Symptom experience after discontinuing use of estrogen plus progestin.
Ockene JK, Barad DH, Cochrane BB, Larson JC, Gass M, Wassertheil-Smoller S, Manson JE, Barnabei VM, Lane DS, Brzyski RG, Rosal MC, Wylie-Rosett J, Hays J. Ockene JK, et al. JAMA. 2005 Jul 13;294(2):183-93. doi: 10.1001/jama.294.2.183. JAMA. 2005. PMID: 16014592
88 results